Simultaneous detection of antibodies against SARS-CoV2 and variants to assess cross-immunity

CoViDiag+ is an High-Definition COVID-19 serological device. Based on CoViDiag test which simultaneously detects and identifies 4 antibodies produced against the SARS-CoV-2 virus, CoViDIag+ is offering to enlarge again immune profile with the detection of antibodies cross-reacting with 4 variants (Alpha, Beta, Gamma, Delta, Omicron).

The addition of RBD domains from 4 SARS-CoV2 variants offers to compare antibody response intensities to improve evaluation of cross immunity between different virus strains.

Perfectly automatable on several mainstream devices, CoViDiag+ is a very competitive technology, that enables to test and characterize several hundred samples a day. 

Key points of CoViDiag+

• Up-to-date : Based on the CoViDiag serological test CoViDiag+ is updated with Ag from variants as soon as they are available
• Simplicity : same protocol as an ELISA test
• Flexibility : Various isotypes detection 
• Adaptability : Standard lab equipment : Quick visual interpretation**

**Automated interpretation is available on a specific reader.

CoViDiag Product Range